Document is current

Article History

Received: 19 August 2025

Revised: 16 December 2025

Accepted: 22 December 2025

First Online: 6 January 2026

Declarations

:

: Kazutaka Sunami received honoraria from BMS, Janssen Pharmaceutical K.K., Pfizer, and Sanofi; received grants or contracts from Ono Pharmaceutical Co., BeiGene, AbbVie, Sanofi, BMS, GSK, Chugai Pharmaceutical Co. Ltd., Otsuka, Janssen Pharmaceutical K.K., Novartis Pharmaceuticals, Pfizer, Kyowa Kirin, Mitsubishi Tanabe, and Incyte. Hiroshi Handa received grants or contract from Johnson & Johnson, BMS, Sanofi, Pfizer, GSK, Ono Pharmaceutical Co.; received honoraria from Johnson & Johnson, BMS, and Pfizer. Michiko Ichii received honoraria from Sanofi, Takeda Pharmaceutical, Novartis Pharmaceuticals, Bristol Myers Squibb, Janssen Pharmaceutical K.K., Ono Pharmaceutical Co., and Chugai Pharmaceutical Co. Ltd.; consulting fees from GSK. Takayuki Ikezoe received honoraria from Sanofi; support for attending meeting/travel from Sanofi, BMS, Janssen Pharmaceutical K.K. Kazuhito Suzuki received consulting fees from GSK; honoraria from Janssen Pharmaceutical K.K., and Ono Pharmaceutical Co; Dr. Kazuhito Suzuki is an editor for International Journal of Hematology. Shigeki Ito is an editor for International Journal of Hematology; received honoraria from Johnson & Johnson and Sanofi; participated on an advisory board for GSK and Pfizer. Yusuke Yamaguchi, Taeko Yonekawa, Elisabet Manasanch, and Hitomi Kato are employed by GSK. Akira Endo, Ianire Garrobo Calleja, Eric Lewis, and Hirofumi Nakano are employed by GSK and hold financial equities in GSK.